Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
06/2009
06/24/2009CN101466830A Polypeptides and biosynthetic pathways for the production ofstereoisomers of monatin and their precursors
06/24/2009CN101463347A Luciferase stabiliser
06/24/2009CN101463346A Enzyme composition and use thereof in beer brewing
06/24/2009CN100503819C Human soman hydrolase
06/24/2009CN100503818C Ultrafiltration cleaning of enzyme
06/23/2009USRE40789 Mammalian checkpoint proteins polypeptides and encoding sequences thereof
06/23/2009US7550651 Nucleic acid fragments; seeds; oilseed plants
06/23/2009US7550647 Transfected shrimp as production systems for therapeutic proteins
06/23/2009US7550573 Nucleotide sequences coding polypeptides for use in the treatment of thrombosis, arthritis and cell proliferation defects
06/23/2009US7550571 Lafora's disease gene
06/23/2009US7550563 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (Ig-like) domain
06/23/2009US7550427 Poly-pegylated protease inhibitors
06/23/2009US7550424 aromatic and heterocyclic sulfonamides, to treat preneoplastic and/or neoplastic diseases by specifically inhibiting the carbonic anhydrase activity of the oncoprotein now known alternatively as the MN protein, the MN/CA IX isoenzyme
06/23/2009US7550295 using modified vaccinia topoisomerase enzyme containing an affinity tag to facilitate purification of protein-DNA complexes away from unbound DNA; ligating duplex DNAs; cloning DNA by introducing into a cell ligated duplex DNA
06/23/2009US7550286 Docosahexaenoic acid producing strains of Yarrowia lipolytica
06/23/2009US7550282 Biological glue based on thrombin-conjugated nanoparticles
06/23/2009US7550281 Method for production of alpha-amylase in recombinant Bacillus
06/23/2009US7550280 Lipases and uses thereof
06/23/2009US7550277 Polypeptides catalyzing reductive amination of pyruvate, cyclohexylpyruvate, phenylpyruvate, 2-ketoacid to its corresponding D-amino acid; mutagenesis of a diaminopimelate dehydrogenase; contact polypeptide to nicotinamide cofactor and ammonia; fine chemical industry
06/23/2009US7550274 Glucose dehydrogenase
06/23/2009US7550262 Identifying defects in protein tyrosine phosphatase gene and diagnosing and treating leukemic blood disorder
06/23/2009CA2173822C Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion molecules in e. coli
06/23/2009CA1341597C Mutant human tissue-type plasminogen activator with a modified carbohydrate structure at amino acid residue 117
06/18/2009WO2009076655A2 Synthetic enzymes derived from computational design
06/18/2009WO2009076621A1 High resolution structures of acidic mammalian chitinases and uses thereof
06/18/2009WO2009076539A2 Modulation of protein degradation and uses thereof
06/18/2009WO2009076490A1 Use of cathepsin l antagonists in the treatment of bone disease
06/18/2009WO2009076426A1 Engineering zymogen for conditional toxicity
06/18/2009WO2009076292A2 Rationally-designed meganucleases with recognition sequences found in dnase hypersensitive regions of the human genome
06/18/2009WO2009076122A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same
06/18/2009WO2009075825A2 Translocation and mutant tnk1 kinase in human lymphoma
06/18/2009WO2009075798A2 Hydrogenase polypeptide and methods of use
06/18/2009WO2009075682A1 Mashing process
06/18/2009WO2009074843A1 Genetically modified plants displaying reduced accumulation of cadmium
06/18/2009WO2009074650A2 Brewing process
06/18/2009WO2009074158A1 Crystal structure of a type iic p-type atpase
06/18/2009WO2009074156A1 Crystal structure of a plasma membrane proton pump
06/18/2009WO2009073977A1 Polypeptides modified by protein trans-splicing technology
06/18/2009WO2009059254A3 Methods for the economical production of biofuel precursor that is also a biofuel from biomass
06/18/2009WO2009024142A3 Protease-stable, cell wall-lysing enzymes
06/18/2009WO2009001304A9 Modified 13-hydroperoxide lyases and uses thereof
06/18/2009WO2008154012A3 Treatments involving glutaredoxins and similar agents
06/18/2009WO2005084366A3 Transcription factor rna interference reagents and methods of use thereof
06/18/2009WO2003072760A3 Method for cloning and expression of bsawi restriction endonuclease and bsawi methylase in e. coli
06/18/2009WO2003060153A3 Irak-m is a negative regulator of toll-like receptor signaling
06/18/2009US20090158470 Compositions and methods for the treatment of Pierce's Disease
06/18/2009US20090158464 Soybean promoter ltp4 and flower-preferred expression thereof in transgenic plants
06/18/2009US20090158461 Transcription Factor Stress-Related Proteins and Methods of Use in Plants
06/18/2009US20090158460 Plant Diacylglycerol Acyltransferases
06/18/2009US20090158455 Compositions and methods for modulating lysine production
06/18/2009US20090158454 Lecitin-like protein kinase stress-related polypeptides and methods of use in plants
06/18/2009US20090158451 Indoleamine 2,3-Dioxygenase-2
06/18/2009US20090158448 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity
06/18/2009US20090156687 Fab I and inhibition of apicomplexan parasites
06/18/2009US20090156622 2,4-pyrimidinediamine compounds and their uses
06/18/2009US20090156594 Heterocyclic kinase modulators
06/18/2009US20090156557 Kinase inhibitors
06/18/2009US20090156476 Dimeric or Multimeric Microproteins
06/18/2009US20090156466 Characterization of a MEKK binding site and uses thereof
06/18/2009US20090156457 Methods and means for screening for rhomboid activity
06/18/2009US20090156430 Promoter and plasmid system for genetic engineering
06/18/2009US20090155882 reduced capability of cleaving a substrate close to the branching point, and improved substrate specificity; for industrial starch processing such as liquefaction or saccharification; for use in detergents, papermaking and textile treatment
06/18/2009US20090155881 Cell-free protein synthesis method and cell-free protein synthesis reaction solution using adenosine 3',5'-bisphosphate
06/18/2009US20090155880 Mutant protein having diaphorase activity
06/18/2009US20090155879 Reconstitution of 5-enolpyruvylshikimate-3-phosphate synthase activity by fragment complementation
06/18/2009US20090155875 Methods to Enhance Carbon Monoxide Dehydrogenase Activity and Uses Thereof
06/18/2009US20090155865 Esterases and their Use for Processes for Kinetic Resolution of Butinolesters
06/18/2009US20090155863 Ketoreductase polypeptides and uses thereof
06/18/2009US20090155857 Facilitator and method for amplification
06/18/2009US20090155850 Horse:Human Chimeric Antibodies
06/18/2009US20090155849 Generation of specific adhesion in gram-negative bacteria by means of anchoring immunoglobulin single domains on their surface with autotransporters
06/18/2009US20090155847 Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
06/18/2009US20090155834 Methods for identifying agents which alter histone protein acetylation, decrease aging or increase lifespan
06/18/2009US20090155829 Heme choline esters and uses thereof
06/18/2009US20090155828 Methods of detecting prostate cancer
06/18/2009US20090155802 Mutant DNA Polymerases with Improved Pyrophasphorolysis Activated Polymerization (PAP) Ability
06/18/2009US20090155789 Genes from the 20q13 amplicon and their uses
06/18/2009US20090155787 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
06/18/2009US20090155775 Cloned dna polymerases from thermotoga and mutants thereof
06/18/2009US20090155771 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same
06/18/2009US20090155418 ABFB-1 Gene of Penicillium Funiculosum
06/18/2009US20090155413 Enzyme
06/18/2009US20090155411 Metabolically engineered lactic acid bacteria and their use
06/18/2009US20090155296 based on a native version of the enzyme from E. corrodens and induces production of antibodies that inhibit the activity of the lysine decarboxylase enzyme in the oral cavity; comprising a substitution at a position corresponding to position 365 of SEQ ID NO:2
06/18/2009US20090155276 NOVEL DKKL-1 Splice Product Modulators for Cancer Diagnosis and Therapy
06/18/2009US20090155248 Antibodies to MT-SP1 serine protease
06/18/2009US20090155241 Prophylactic/therapeutic agent for cancer
06/18/2009US20090155239 Novel Protease, Microorganism Producing the Same, and Application Thereof
06/18/2009US20090155238 Xylanases, nucleic acids encoding them and methods for making and using them
06/18/2009US20090155236 Peptide sequence for modulation of delta protein kinase c
06/18/2009CA2709107A1 Compositions and methods for producing isoprene
06/18/2009CA2708609A1 Engineering zymogen for conditional toxicity
06/18/2009CA2708268A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same
06/18/2009CA2708108A1 Hydrogenase polypeptide and methods of use
06/18/2009CA2707979A1 Polypeptides modified by protein trans-splicing technology
06/18/2009CA2703079A1 Rationally-designed meganucleases with recognition sequences found in dnase hypersensitive regions of the human genome
06/17/2009EP2071024A1 Peptides of human prostatic acid phosphatase enhancing viral infectivity
06/17/2009EP2071023A2 Novel enzyme
06/17/2009EP2071022A1 S-adenosylmethionine synthetase mutants, the dnas encoding the same and uses of the mutants
06/17/2009EP2070968A2 Method for the Preparation of 1-Benzotriazolyl Carbonate Esters of Poly(ethylene glycol)